Methotrexate labelling safety — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — Correct the label to the prescribed weekly dosing before supply
The dispensing label must match the intended safe directions. Daily methotrexate labelling for inflammatory disease is a serious medication-safety risk. The error should be corrected, clinically checked and explained to the patient, with local incident reporting if appropriate.
Reference: BNF; MEP